ACTRN12611001150932已完成2 期
A Double-Blind Randomised Placebo-Controlled Trial Of The Effects Of Fenofibrate And Coenzyme Q10 On Arterial Function In Type 2 Diabetic Subjects With Dyslipidaemia
Professor Gerald F Watts0 个研究点目标入组 80 人开始时间: 2011年11月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Type 2 diabetes
- •Dyslipidaemia (fasting serum triglycaeride >1.8mmol/L or HDL-cholesterol <1.0mmol/L, with total cholesterol <6.5mmol/L and total cholesterol-to-HDL-cholesterol ratio >4)
排除标准
- •Use of antioxidant or lipid-regulating therapy, insulin, angiotensin-converting enzyme inhibitors, calcium antagonists or aspirin
- •Body mass index >40kg/m2
- •Uncontrolled hypertension (>160/90mmHg)
- •Serum creatinine >150umol/
研究者
相似试验
已完成
3 期
Effect of Lignocaine Infusion in Colorectal Cancer Patient Immune CellsCancer - Bowel - Back passage (rectum) or large bowel (colon)Inflammatory and Immune System - Other inflammatory or immune system disordersAnaesthesiology - Pain managementSurgery - Other surgerycolon cancerACTRN12618000754246Hunter New England Local Health District107
已完成
4 期
Effect of Vitamin D3 on Functions of Kidney and Blood Vessels in Vitamin D Deficient Patients with Type 2 Diabetes MellitusCTRI/2017/12/010785Intramural fund100
已完成
不适用
A Randomized Double-Blind Placebo-Controlled Trial of efficacy of phloroglucinol in Irritable Bowel SyndromeDiseases of the digestive systemKCT0000494Chung-Ang Univerisity Hospital72
进行中（未招募）
不适用
A Randomized Double-Blind Placebo Controlled Trial Evaluating the Safety and Efficacy of Etanercept 25 mg Twice Weekly in Subjects with Moderate to Severe Persistent AsthmaModerate to severe asthmaticsEUCTR2004-003778-27-FIWyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical resaearch and Development120
进行中（未招募）
1 期
A Randomized Double-Blind Placebo Controlled Trial Evaluating the Safety and Efficacy of Etanercept 25 mg Twice Weekly in Subjects with Moderate to Severe Persistent AsthmaModerate to severe asthmaticsEUCTR2004-003778-27-GBWyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical resaearch and Development120